Hirotsu, Nobuo
Sakaguchi, Hiroki
Fukao, Keita
Kojima, Satoshi
Piedra, Pedro A.
Tsuchiya, Kenji
Uehara, Takeki
Funding for this research was provided by:
Shionogi
Article History
Received: 9 August 2022
Accepted: 9 January 2023
First Online: 21 January 2023
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. Ethics approval was obtained by the institutional review board or ethics committee at each study center. A list of the institutional review boards is provided in Additional file InternalRef removed: Table S5. Parents/legal guardians of participating patients provided written informed consent; participating children gave oral or written informed assent according to their capabilities.
: Not applicable.
: Keita Fukao, Kenji Tsuchiya, and Takeki Uehara are employees of Shionogi & Co., Ltd. Hiroki Sakaguchi and Satoshi Kojima are employees and own shares in Shionogi & Co., Ltd. Nobuo Hirotsu has received personal fees for lectures and non-financial support from Shionogi & Co., Ltd. Pedro A. Piedra has received research funding from Shionogi & Co., Ltd. and advisory fees from F. Hoffmann-La Roche Ltd.